Medical Test Maker Venaxis, Inc. Banks $18.4 Million, Files For FDA Approval

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Venaxis, a small medical diagnostics company in Castle Rock, CO, has raised $18.4 million through a public offering that closed Monday.

Venaxis (NASDAQ: APPY) is developing a protein biomarker-based blood test doctors can use to diagnose whether a patient has acute appendicitis. The test, known as APPY1, is intended to be used in emergency rooms to rule out whether a patient has developed the condition.

Help employers find you! Check out all the jobs and post your resume.

Back to news